News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McCain Tracey L
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2023 |
4
| McCain Tracey L (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Exercised 5,000 options to buy
@ $0 |
|
| 06/16/2023 |
4
| McCain Tracey L (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 13,090 restricted stock units
@ $0
Granted 19,597 options to buy
@ $0 |
|
| 06/08/2023 |
4
| McCain Tracey L (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 26,236 options to buy
@ $15.19, valued at
$398.5k
Granted 4,373 options to buy
@ $0 |
|
| 03/08/2023 |
4
| McCain Tracey L (EVP AND CHIEF LEGAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 3,216 shares
@ $45.72, valued at
$147k
Sold 106 shares
@ $44.41, valued at
$4.7k
|
|
| 03/03/2023 |
4
| McCain Tracey L (EVP AND CHIEF LEGAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| McCain Tracey L (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 2,876 restricted stock units
@ $0 |
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| McCain Tracey L (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 2,888 restricted stock units
@ $0 |
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| McCain Tracey L (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 30,000 restricted stock units
@ $0
Granted 44,000 options to buy
@ $5.68, valued at
$249.9k
|
|
| 11/05/2021 |
4
| McCain Tracey L (EVP and Chief Legal Officer) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 4,200 shares
@ $110.74, valued at
$465.1k
Sold 800 shares
@ $109.63, valued at
$87.7k
Exercised 5,000 options to buy
@ $28.36, valued at
$141.8k
|
|
| 09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2021 |
4
| McCain Tracey L (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 33,237 options to buy
@ $14.33, valued at
$476.3k
|
|
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| McCain Tracey L (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 18,760 options to buy
@ $25.48, valued at
$478k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2019 |
4
| McCain Tracey L (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 18,760 options to buy
@ $15.47, valued at
$290.2k
|
|
| 03/05/2019 |
4
| McCain Tracey L (EVP and Chief Legal Officer) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 29,900 options to buy
@ $86.6, valued at
$2.6M
Granted 8,050 restricted stock units
@ $0 |
|
| 03/01/2018 |
4
| McCain Tracey L (EVP and Chief Legal Officer) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 100 shares
@ $90.75, valued at
$9.1k
Sold 8,794 shares
@ $88.4, valued at
$777.4k
Sold 1,106 shares
@ $87.69, valued at
$97k
Exercised 10,000 options to buy
@ $28.36, valued at
$283.6k
|
|
| 02/20/2018 |
4
| McCain Tracey L (EVP and Chief Legal Officer) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 39,000 options to buy
@ $81.44, valued at
$3.2M
|
|
| 02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|